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Bronchial asthma is a chronic inﬂammatory disease based on an inappropriate stimulation
of the immune system, for instance by environmental aeroallergens. It is characterised by
bronchial hyperreactivity, reversible airway obstruction and mucus overproduction.
During the last decades bronchial asthma has become the most common disease of
childhood. Accordingly, many epidemiological and genetic studies have dealt with its
origin. In fact, hundreds of genome-wide linkage analyses and association studies have
identiﬁed several chromosomal regions harbouring asthma susceptibility genes like
chromosome 2q, 5q, 6q, 11q, 12q and 13q. Also about 100 candidate genes for asthma
have been described. However, not all of them have been conﬁrmed in independent
studies.
Besides the genetic predisposition environmental factors play an important role in the
development of allergic diseases. Studies predominantly performed in farmer children
have shown that exposure to bacterial endotoxin early in life reduces the risk to develop
asthma or atopy later on. Thus, recent studies focussed also on the interaction of genes
variants with environmental factors which is summarised under the term genetic
epidemiology.
Further dissection of asthma genetics and its complex interaction with surrounding factors
will hopefully help us in the development of new very speciﬁc drugs. In addition, the
generation of a genetic risk proﬁle for bronchial asthma should enable us for the ﬁrst time
to take well-directed preventive measurements early in live.
& 2007 Elsevier Ltd. All rights reserved.Contents
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describe. In fact, hundreds of different deﬁnitions have
been used to characterise the disease. Most commonly
asthma is referred to as reversible obstruction of the
airways, accompanied by mucus overproduction and bron-
chial hyper reactivity to speciﬁc and non-speciﬁc stimuli. In
addition, asthmatic patients show a pronounced inﬂamma-
tion of their airways. In children, asthmatic exacerbation is
predominantly caused by allergic triggers, like exposition to
house dust mites or pollen. In contrast, asthma in adults is
mainly intrinsic.
The incidence of asthma has continuously risen during the
last decades.1,2 Since about 10 years the prevalence seems
to have reached a steady state. Still, bronchial asthma
represents the most common chronic disease in childhood
and is a major challenge for health care. A wide variety of
epidemiological and genetic studies on asthma have been
conducted worldwide. The many different deﬁnitions of
asthma and related phenotypes and the discrepancy
between childhood and adult asthma make it difﬁcult—if
not even impossible—to compare many of these studies.
The genetic predisposition to asthma is highly complex.
Some features of complex genetic diseases are illustrated in
Fig. 1: First complex diseases are characterised by genetic
heterogeneity. Thus, different gene polymorphisms in
several genes might cause asthma independently from each
other. Furthermore, only the interaction of these poly-
morphisms within different genes might deﬁne the indivi-
dual genetic risk to develop allergic diseases.3 The power of
this interaction might be different from the mere addition of
the effects of the polymorphisms when occurring separately,
this is known as epistasis.
The dissection of complex genetic diseases is further
hampered by difﬁculties to recruit suitable individuals: Due
to an incomplete penetrance individuals actually bearing a
predisposing polymorphism might be healthy and thus
classiﬁed as controls. On the other hand, some patients might
be asthmatic solely due to environmental stimuli without any
genetic predisposition, because of a high phenocopy rate.
For the performance of genetic studies reproducible and
clear-cut deﬁnitions are essential as the impact of one single
polymorphism on disease development is rather small and can
only be detected in homogenous study populations. Thus, the
use of so-called intermediate phenotypes has been proposed.
Intermediate phenotypes are distinguished facets of asthma,
like bronchial hyper reactivity or sensitisation to a speciﬁc
allergen. Obviously levels of speciﬁc IgEs can be measured
reliably across different populations and thus enables the
generation of uniform populations. However, genetic associa-
tion found with intermediate phenotypes might not necessa-
rily be representative for bronchial asthma.How to ﬁnd genes for complex genetic diseases
Basically three different approaches exist for mapping
candidate genes for complex genetic diseases like asthma:
The genome-wide linkage analysis has been widely used in
the past. In its classical manner genetic markers—so-called
microsatellites—are genotyped in families with at least two
affected children. Subsequently, those chromosomal regions
are identiﬁed by statistical analyses, which are transmitted
more often to the affected children than expected by chance.
Thus, all chromosomal regions harbouring genes with major
effects on the susceptibility to asthma should be identiﬁed
without any former knowledge of the function of these genes.
However, the regions found by genome-wide linkage analyses
are still very large and typically harbour hundreds of genes.
Second, association studies of candidate genes can be
conducted. Here a gene is selected for further investigation
because its already known function implicates an involve-
ment in the pathophysiology of asthma. Association studies
are often performed in unrelated case and control samples
by the comparison of the allelic or genotypic distribution
between both groups. Obviously, only genes with known
function can be studied by this approach whereas it is not
possible to ﬁnd any new genes.
A third approach has only evolved very recently: Genome
wide association studies using single nucleotide polymorph-
isms (SNPs) have become feasible due to the development of
high through-put technology. Here hundreds of thousands of
SNPs are typed by means of Microarrays technology in one
single experiment. The ﬁrst studies using these techniques
are currently performed. The results are expected with
great interest as they will allow a genome wide look on
asthma genes for the ﬁrst time. However, the statistical
analyses of the vast amount of genotypes gained by this
method are still a major challenge.
Once, association between a polymorphism and the disease
of interest has been established several scenarios exist:1. The polymorphism actually affects disease status, possi-
bly by changing the function of the gene. For example,
this could be due by altering transcriptional activity or by
causing amino-acid changes in the encoded protein.2. The real disease causing polymorphism is inherited
together with the analysed SNP because of existing
linkage disequilibrium (LD). It has been demonstrated
that LD extends across hundreds of thousands of base
pairs. In that case it would be difﬁcult if not impossible to
deﬁne the true disease-causing variant by statistical
analyses. Instead functional studies are needed.3. The association might be false positive (type I error). This
could be due to genotyping errors, population stratiﬁca-
tion, not correcting for multiple testing or by chance to
name just a few.
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Figure 1 This ﬁgure illustrates some characteristic features of complex genetic diseases. Further explanation is provided in the
text.
The genetics of bronchial asthma in children 1371If several polymorphisms within the same chromosomal
region have been genotyped it is advisable to perform
haplotype analyses in addition to single polymorphism
analyses. A haplotype indicates those SNPs which are
transmitted together on a single allele. This is important
because polymorphisms on the same allele might intensify or
attenuate their effects.Genes for asthma
Since the beginning in asthma genetic research about 20
years ago, a bundle of genome-wide linkage screens for
asthma and related atopic phenotypes have been performed
in ethnic diverse populations. Thereby—bit-by-bit—nearly
the whole genome was found in linkage to asthma in one or
more populations. However, some regions have been found
repetitively and thus are most likely to be real. These
regions with strongest evidence for harbouring asthma
susceptibility genes are chromosome 2q,4–7 5q, 6q,4,8–11
11q,12 12q13,14 and 13q.15,16 In the following these regions
and the most prominent candidate genes are brieﬂy
described.
On chromosome 2q32-q33 cytotoxic T-lymphocyte-asso-
ciated protein 4 (CTLA-4) is the most prominent candidate
gene. CTLA-4 is involved in T-cell activation and regulation
of IgE. Chromosome 5q31 contains several candidate genes
like interleukin (IL)-4, IL-13, IL-5, cluster of differentiation
(CD14) and granulocyte macrophage colony stimulatingfactor (GM-CSF), which are possibly important for the
development and progression of inﬂammation associated
with allergy and asthma. On chromosome 6, the major
histocompatibility complex (MHC) region is located contain-
ing many molecules involved in innate and speciﬁc im-
munity. Genes of the MHC class II have been shown to
inﬂuence the ability to respond to particular allergens.
The b chain of FceRI, the high afﬁnity receptor for IgE, is
localised on chromosome 11q13; variation of the b chain
may affect the stability of the receptor during surface
expression and possibly modify receptor function.17 On
chromosome 12q13 signal transducer and activator of
transcription 6 (STAT6) is one of many candidate genes
because it plays an important role in IL-4/IL-13 signalling.
The chromosomal region 13q14 has been demonstrated to be
linked to total serum IgA and IgE levels. Meanwhile the
causative gene has been identiﬁed by positional cloning.18
It is assumed that each region in linkage rather contains
many asthma genes with small effects than a single major
gene. Accordingly, just in the last 2 years more than 100
genes have been described in association with asthma or
atopy. Not all of them have been conﬁrmed in subsequent
independent studies.19 The conﬂicting results are mainly
due to differing phenotypes under investigation, small
sample sizes and the different ethnicity of the study
populations. Figure 2 provides information about these
genes and the number of study samples in which the positive
results were validated—or could not be conﬁrmed, respec-
tively: The following genes have been found in association
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Figure 2 Genes found in association with asthma or related phenotypes in at least one published study (ﬁgure from Ober and
Hoffjan19). Genes only studied once are separated from those genes that have been investigated but not conﬁrmed in subsequent
studies (numbers in parentheses denote the numbers of subsequent studies). Genes identiﬁed by positional cloning are underlined.
S. Bierbaum, A. Heinzmann1372with asthma or atopy in at least 10 independent studies and
thus might represent the elite group of asthma genes: IL-4,
IL-13, CD14 and b2 adrenergic receptor (ADRB2) on
chromosome 5, human leukocyte antigen DRB1 and DQB1
(HLA-DRB1, HLA-DQB1) and tumour necrosis factor (TNF) on
chromosome 6, high-afﬁnity IgE receptor (FCER1B) on
chromosome 11, IL-4 receptor (IL4RA) on chromosome 16
and a disintegrin and metalloproteinase domain 33
(ADAM33) on chromosome 20. Interestingly, ADAM33 was
the ﬁrst asthma gene that was identiﬁed by positional
cloning.20Overlap with other inﬂammatory diseases
In 1998, Becker and colleagues described for the ﬁrst time,
that several inﬂammatory diseases like diabetes mellitus,
bronchial asthma, psoriasis, multiple sclerosis and chronic
inﬂammatory bowel disease are genetically linked to the
same chromosomal regions.21 Subsequently this observation
was conﬁrmed by additional linkage and association studies.
Depending on the predominant immune response, chronic
inﬂammatory disease can be subdivided in T helper cell (TH)1 or TH2 diseases. Crohn’s disease, diabetes mellitus,
rheumatoid arthritis and other autoimmune disorders are
classical TH1 diseases, whereas allergic diseases are
dominated by TH2 immune response (see Fig. 3).22 Thus an
opposite effect of gene variants on both groups of diseases
seems to be self-evident.
In fact, for some genes this has been demonstrated:
Analyses of the amino acid variant Gln110Arg within IL-13
demonstrated association with asthma and elevated IgE
levels.23–25 In addition, a signiﬁcant inverse distribution of
the same polymorphism was found in a population of
children with juvenile idiopathic arthritis. These results
might indicate that the same variant protects from
rheumatoid arthritis, but increases susceptibility to asthma.
Similar results were achieved with IL-8, IL-4, CTLA-4 and
TNFalpha for asthma, arthritis and chronic bowel dis-
eases.26–29
However, also identical effects of polymorphisms on TH1
and TH2 diseases have been reported: Polymorphisms in
caspase recruitment domain containing protein 15
(CARD15), an intracellular LPS receptor protein, have been
associated with allergic rhinitis, atopic dermatitis and
increased IgE levels as well as with Crohn’s disease.30
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Figure 3 The immune balance (ﬁgure from Smit et al.22). If activity of regulatory T cells is low, deregulated immune response will
develop. The nature of this exaggerated immune response depends on the pre-existing balance between T helper type (TH) 1
(autoimmune disease) and TH2 (asthma, allergy).
The genetics of bronchial asthma in children 1373The fact that a genetic relationship exists between Crohn’s
disease and atopy may indicate that the analysed variants
lead to an impaired recognition of microbial components
resulting in an insufﬁcient down regulation of excessive
immune response by so-called T regulatory cells (see also
Fig. 3). This could favour a dominant TH2 immune response
in the case of allergies or a predominant TH1 immune
response in the case of Crohn’s disease.Genes and environment: epidemiological genetics
While investigations of the causes of allergic diseases are
still in progress, strong evidence exists for the interaction of
genetic and environmental factors on the development of
these disorders.31–33 Numerous epidemiological studies have
demonstrated that environmental factors inﬂuence, trigger
or even protect from allergic diseases.34 Although twin
studies suggest that genes may play a more important role
for the development of allergy than environmental factors,
biological interactions between genes and environment
could be crucial.
In the dissection of gene–environment interaction, genes
of the innate immunity are perfect candidates, as they are
positioned at the interface between microbes and the
immune system. One gene that has been studied in
epidemiological, genetic and functional terms is CD14, a
component of the pathogen-recognition receptor class
complexes. As mentioned above, CD14 is located on
chromosome 5q31.33, a region repetitively linked to Th2
phenotypes like increased IgE levels, eosinophilia and
allergic asthma11,35–37; it is expressed on the surface of
macrophages and monocytes and is also secreted as soluble
form (sCD14). CD14 determines the development of immune
responses to low concentrations of microbial molecules,
especially via Toll-like receptor (TLR) 4 and TLR2 by
enhancing the afﬁnity and/or avidity of the interaction
between pathogen products and TLRs.38
Investigations on a SNP in the promoter of CD14 have
shown that the same variant may lead to distinct transcrip-
tional patterns if the gene is expressed at different times
and/or different cell types. Analyses of this promoterpolymorphism by Eder et al.39 have indicated that this
polymorphism exhibits a protective effect against increased
IgE levels in children with intermediate exposure to farm
animals whereas high levels of IgE were observed in children
highly exposed to stable animals. These results implicate
that the same polymorphism could be linked to different and
even opposite phenotypes, in dependence on environmental
conditions.
Interaction of polymorphisms with environmental factors
in the development of asthma in children has also been
shown for the following genes: gluthatione S transferase
(GST) and exposure to tobacco smoke40; GSTP1 and air
pollution41; as well as for TLR2 and CARD4 and farmer
life.42,43Genes and environment: the hygiene hypothesis
Furthermore, several studies—predominantly performed in
farmer children—have demonstrated that exposure to
bacterial endotoxin early in life correlates inversely with
the frequency of atopic asthma, hay fever and sensitization
against common aeroallergens in school-aged children.
Thus, the increasing frequency of allergic diseases during
the last decades may be—at least partially—attributed to
the modern westernised lifestyle. Already in 1989, a similar
observation has lead to the formulation of the so-called
hygiene hypothesis by Strachan.44 The hypothesis suggests
that exposure to microbes, other pathogens and their
products early in life leads to a priming of the immune
response towards TH1 direction (associated with bacterial
and viral infections) whereas an almost sterile environment
and less infections increases the risk for developing allergies
by shaping the immune answer towards a TH2 proﬁle.
Another aspect might be in support for the interaction
between exposure to pathogens and the development of
allergic diseases. For a number of genes it has been shown,
that the same polymorphism is in association with allergic
diseases and a better defence against helminth infection.
This applies for IL-13,45 FceRI,46 b2-adrenergic receptor
47
and recently the acidic mammalian chitinase (AMCase).48
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S. Bierbaum, A. Heinzmann1374Interestingly, Gerrard et al.49 formulated already in 1976
on the basis of epidemiological data the following sentence:
‘‘It is suggested that atopic disease is the price paid by some
members of the white community for their relative freedom
from diseases due to viruses, bacteria and helminths.’’ This
might be especially true for genes involved in the defence of
pathogens.Conclusion
Though almost 20 years of research into asthma genetics
have passed by the present knowledge in this ﬁeld is still
confusing and in parts might be even rudimental. The
description of more than 100 asthma genes has surely
improved our current understanding of the pathophysiology
of the disease but also raised many new questions and
challenges.
An important goal for future studies is to elucidate the
complex interaction between genes and environment.
Identifying the most important asthma genes in the context
of environmental factors could facilitate the setting up of a
genetic risk proﬁle for the development of asthma. This
would enable us for the ﬁrst time to take preventive
measures early in live for children with an increased genetic
risk to develop allergic diseases. Knowing the most
important asthma genes would also help in the design of
new drugs which are more speciﬁc, effective and save. Thus
in consideration of the new technologies and possibilities in
asthma genetics research the expectations for the years to
come are high.References
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